Lopez-Pajares Vanessa, Kim Mihee M, Yuan Zhi-Min
Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
J Biol Chem. 2008 May 16;283(20):13707-13. doi: 10.1074/jbc.M710030200. Epub 2008 Mar 20.
The critical tumor suppressor p53 is mutated or functionally inactivated in nearly all cancers. We have shown previously that the MDM2-MDMX complex functions as an integral unit in targeting p53 for degradation. Here we identify the small protein 14-3-3 as a binding partner of MDMX, which binds at the C terminus (Ser367) in a phosphorylation-dependent manner. Importantly, we demonstrate that the serine/threonine kinase Akt mediates phosphorylation of MDMX at Ser367. This phosphorylation leads to stabilization of MDMX and consequent stabilization of MDM2. Previous studies have shown that Akt phosphorylates and stabilizes MDM2. Our data suggest that stabilization of MDMX by Akt may be an alternative mechanism by which Akt up-regulates MDM2 protein levels and exerts its oncogenic effects on p53 in tumor cells.
关键肿瘤抑制因子p53在几乎所有癌症中都发生了突变或功能失活。我们之前已经表明,MDM2-MDMX复合物作为一个整体单元,在靶向p53进行降解方面发挥作用。在此,我们鉴定出小蛋白14-3-3是MDMX的一个结合伴侣,它以磷酸化依赖的方式在C末端(Ser367)结合。重要的是,我们证明丝氨酸/苏氨酸激酶Akt介导MDMX在Ser367位点的磷酸化。这种磷酸化导致MDMX的稳定以及随之而来的MDM2的稳定。先前的研究表明Akt使MDM2磷酸化并使其稳定。我们的数据表明,Akt对MDMX的稳定作用可能是Akt上调MDM2蛋白水平并在肿瘤细胞中对p53发挥致癌作用的一种替代机制。